Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  atrasentan

atrasentan

Basic information Safety Supplier Related

atrasentan Basic information

Product Name:
atrasentan
Synonyms:
  • atrasentan
  • (2R,3R,4S)-4-(1,3-Benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid
  • (+)-A 127722
  • A-147627
  • (2R,3R,4S)-4-(1,3-Benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)-3-pyrrolidinecarboxylic acid
  • (2S,3S,4R)-4-(1,3-BENZODIOXOL-5-YL)-1-[2-(DIBUTYLAMINO)-2-OXOETHYL]-2-(4-METHOXYPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID
  • A127722, CID 5310990
  • Atrasentan (ABT-627)
CAS:
173937-91-2
MF:
C29H38N2O6
MW:
510.62
Product Categories:
  • API
Mol File:
173937-91-2.mol
More
Less

atrasentan Chemical Properties

Melting point:
122-124°
Boiling point:
659.4±55.0 °C(Predicted)
Density 
1.188±0.06 g/cm3(Predicted)
storage temp. 
-20°C Freezer, Under inert atmosphere
solubility 
DMSO (Slightly), Methanol (Slightly)
form 
Solid
pka
3.49±0.60(Predicted)
color 
Off-White
InChIKey
MOTJMGVDPWRKOC-QPVYNBJUSA-N
SMILES
N1(CC(N(CCCC)CCCC)=O)C[C@H](C2=CC=C3OCOC3=C2)[C@@H](C(O)=O)[C@@H]1C1=CC=C(OC)C=C1
More
Less

atrasentan Usage And Synthesis

Uses

Palliative treatment of bone pain due to metastatic prostate cancer and disease progression (endothelin (ETA) receptor antagonist).

Uses

Atrasentan is a selective antagonist of the endothelin-A (ETA) receptor and binds selectively to the ETA receptor, which may result in inhibition of endothelin-induced angiogenesis and tumor cell proliferation.

Definition

ChEBI: Atrasentan is a member of pyrrolidines.

in vivo

Atrasentan (3 mg/kg, p.o.) inhibits the pressor response induced by big endothelin-1 (1 nmol/kg) in pithed rats[1]. Aatrasentan (ABT-627, 10 mg/kg, i.p.) as well as Taxotere alone inhibited the C4-2b tumor growth within the bone environment to some extent in the SCID-hu model[2].

atrasentanSupplier

Gaolai (Shanghai) Pharmaceutical Technology Co., Ltd. Gold
Tel
18862951601
Email
gavinhhbcool@163.com
Wuhan Ruilida Biomedical Technology Co., Ltd. Gold
Tel
18201884268
Email
magean83@163.com
Bayee Biotech (Anqing) Co., Ltd. Gold
Tel
0556-5032306 18917961636
Email
wtx@bayeebio.com
Nantong Hanfang Biotechnology Co. , Ltd. Gold
Tel
hanfangpharma@126.com; 18616537568
Email
hanfangpharma@126.com
Guangzhou Viocon Pharmaceutical Technology Co., Ltd Gold
Tel
13726739909
Email
chenhuini@cti-cert.com